Cargando…
Angiosarcoma of the ovary treated with polyadenosine ribose polymerase Inhibition, a case report and review of the literature
• Primary angiosarcoma of the ovary historically has no standard treatment due to its rarity, and outcomes have been variable. • Olaparib may represent a viable treatment option for primary angiosarcoma of the ovary with a somatic BRCA mutation. • Next-generation sequencing may play an important com...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481173/ https://www.ncbi.nlm.nih.gov/pubmed/37680504 http://dx.doi.org/10.1016/j.gore.2023.101264 |